Background
Use of the 1 In many districts in the UK children born to groups at high risk of tuberculosis are routinely given BCG vaccination at birth. As by definition they have a high incidence of the disease, they make up a large part of the referrals to contact tracing clinics and it is possible that many children are being treated for a response to the BCG vaccination rather than infection with tuberculosis.
The Age in years Age range of children studied (n=194). Apart from the five cases diagnosed at the initial assessment, the diagnosis of tuberculosis was made in four children following their allocation to chemoprophylaxis or no treatment. Two were from the chemoprophylaxis group and two from the non-treated group. No new cases were identified as a result of the questionnaire.
The two children who were not treated initially were a sibling pair who were recent immigrants from the Indian subcontinent. They were 6-5 and 2-5 years old and had no history of contact with tuberculosis. Both had Heaf grade 3 and borderline Mantoux results (5 mm). Because of the lack of contact history they were not treated. At follow up five months later both were symptom-free but had developed hilar lymphadenopathy on the chest radiograph which responded to antituberculous chemotherapy. They remained asymptomatic throughout.
The two children diagnosed following completed chemoprophylaxis were treated as a result of a contact history and positive tuberculin test (with a Heaf conversion in one case). Both presented with non-specific symptoms (abdominal pain three years later and cervical lymphadenopathy 15 months later, respectively). In the first case there was a small speck of calcification on the chest radiograph and both cases had a positive 1 TU Mantoux test. Although neither had a further history of contact with tuberculosis both had further treatment.
If a diagnosis of tuberculosis is accepted in all four cases, the rates of subsequent tuberculosis were 5d and 5 4 per 1000 patient years for the treated and untreated groups respectively. The confidence interval for the difference in the rates is large (-0 74 to + 1-28) because of the small numbers with subsequent tuberculosis.
Discussion
This study shows that treatment decisions based on the use of a 1 TU Mantoux test, rather than a Heaf test, in children with a history of neonatal BCG vaccination reduces the number of children receiving chemoprophylaxis. Although the numbers are small, there is no evidence from this study that this results in an appreciable increase in risk of subsequent disease.
Two children allocated to the no treatment group subsequently developed tuberculosis.
This was due to failure to act on the results of the test rather than lack of diagnostic accuracy. 
